Diagnostics are not exclusively used for the treatment of diseases but also for prediction of diseases. Additionally, it is also used for clinical development of drugs, identify reactions of particular diagnostics to patients, and improving outcomes of patients. Big Market Research reports on diagnostic and biotech industry assists businesses to gain thorough understanding of current and future market status. Additionally, it furnishes an extensive analysis of factors driving and restraining growth of the industry along with opportunities, detailed segmentation, and development trends of the market. Moreover, recent news, standards & regulations, policies, and new findings in the industry are cited. Comprehensive market statistics have been highlighted in the report to aid investors and stakeholders to implement various strategies to consolidate their position and sustain in the market.
No of Reports 2225
This report studies the Bacillus Coagulans market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Bacillus Coagulans market by product type and applications/end industries. The Bacillus Coagulans market was valued at USD xx Million in 2018...
The global liquid handling technology market is expected to reach US$ 5,705.63 Mn in 2027 from US$ 3,201.36 Mn in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027. The key factors that are driving the growth of liquid handling technology market are increasing drug discovery activities, growing biopharmaceutical industry and rising research and development expenses. Whereas,...
The global Sanger sequencing service market is forecasted to reach US$ 1,360.47 Mn in 2027 from US$ 489.43 Mn in 2018. The Sanger sequencing service market is estimated to grow with a CAGR of 12.2% from 2019-2027. The market is driven due to factors such as the increasing providers for Sanger sequencing services and growing applications of Sanger sequencing. However, the shortage of skilled profes...
Global membrane filtration market is valued approximately at USD 12.6 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast period 2019-2026. Membrane filtration is a membrane technology used for the separation of biomolecules and particles for concentration of process fluids. Membrane filtration is widely used for the elimination of microorganis...
This report studies the Gene Synthesis market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Gene Synthesis market by product type and applications/end industries. The Gene Synthesis market was valued at USD xx Million in 2018. It is proj...
This report studies the Spirulina market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Spirulina market by product type and applications/end industries. The Spirulina market was valued at USD xx Million in 2018. It is projected to reach ...
This report studies the Fetal Bovine Serum market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Fetal Bovine Serum market by product type and applications/end industries. The Fetal Bovine Serum market was valued at USD xx Million in 2018...
The global cancer biomarkers market is expected to reach US$ 31,206.00 Mn in 2027 from US$ 12,175.69 in 2018. The market is estimated to grow with a CAGR of 11.1% from 2019-2027. Driving factors such as growing cancer prevalence across the globe, new product launches and FDA approvals, and technological advancements are expected to boost the market over the years. However unfavorable regulatory a...
The global cancer biomarkers market is expected to reach US$ 31,206.00 Mn in 2027 from US$ 12,175.69 in 2018. The market is estimated to grow with a CAGR of 11.1% from 2019-2027. Driving factors such as growing cancer prevalence across the globe, new product launches and FDA approvals, and technological advancements are expected to boost the market over the years. However unfavorable regulatory a...
The global antiviral drug resistance market is expected to reach US$ 4,573.24 Mn in 2027 from US$ 2,572.26 Mn in 2018. The Antiviral drug resistance market is estimated to grow with a CAGR of 6.8% from 2019-2027. The market is driven by factors such as, rise in the incidences of hepatitis diseases and increasing prevalence of HIV/AIDS. However, the availability of alternative approaches may limit ...
The global whole exome sequencing market is expected to reach US$ 3,812.0 Mn in 2027 from US$ 755.68 Mn in 2018. The market is estimated to grow with a CAGR of 19.8% from 2019-2027. The market is driven by the factors such as, reduction in time and cost for sequencing, rising need of molecular diagnosis and increasing application in drug discovery are likely to drive the growth of the whole exome ...
The global immunoassay market is expected to reach US$ 37,987.8 Mn in 2027 from US$ 21,800.0 in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2027. The market for immunoassay is expected to grow, owing to factors such as rising incidences of chronic and infectious diseases, technological advancements in immunoassay devices, and growing biotechnology & biopharmaceutical indus...
The global Helicobacter pylori non-invasive testing market is expected to reach US$ 768.23 Mn in 2027 from US$ 539.70 Mn in 2018. The Helicobacter pylori non-invasive testing market is estimated to grow with a CAGR of 4.1% from 2019-2027. The market is driven by the factors such as, increasing prevalence of Helicobacter pylori bacterial infection, new product launches & FDA approvals, and spreadin...
The global drug abuse testing market is expected to reach US$ 9,393.17 Mn in 2027 from US$ 5,783.71 Mn in 2018. The drug abuse testing market is estimated to grow with a CAGR of 5.7% from 2019-2027. The market is driven by factors such as, increasing consumption of illicit drugs and laws and regulations related to drug abuse. However, dearth of trained laboratory professionals may limit the growth...
The global whole exome sequencing market is expected to reach US$ 3,812.0 Mn in 2027 from US$ 755.68 Mn in 2018. The market is estimated to grow with a CAGR of 19.8% from 2019-2027. The market is driven by the factors such as, reduction in time and cost for sequencing, rising need of molecular diagnosis and increasing application in drug discovery are likely to drive the growth of the whole exome ...
The global antiviral drug resistance market is expected to reach US$ 4,573.24 Mn in 2027 from US$ 2,572.26 Mn in 2018. The Antiviral drug resistance market is estimated to grow with a CAGR of 6.8% from 2019-2027. The market is driven by factors such as, rise in the incidences of hepatitis diseases and increasing prevalence of HIV/AIDS. However, the availability of alternative approaches may limit ...
The global immunoassay market is expected to reach US$ 37,987.8 Mn in 2027 from US$ 21,800.0 in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2027. The market for immunoassay is expected to grow, owing to factors such as rising incidences of chronic and infectious diseases, technological advancements in immunoassay devices, and growing biotechnology & biopharmaceutical indus...
The global drug abuse testing market is expected to reach US$ 9,393.17 Mn in 2027 from US$ 5,783.71 Mn in 2018. The drug abuse testing market is estimated to grow with a CAGR of 5.7% from 2019-2027. The market is driven by factors such as, increasing consumption of illicit drugs and laws and regulations related to drug abuse. However, dearth of trained laboratory professionals may limit the growth...
The global Helicobacter pylori non-invasive testing market is expected to reach US$ 768.23 Mn in 2027 from US$ 539.70 Mn in 2018. The Helicobacter pylori non-invasive testing market is estimated to grow with a CAGR of 4.1% from 2019-2027. The market is driven by the factors such as, increasing prevalence of Helicobacter pylori bacterial infection, new product launches & FDA approvals, and spreadin...
The global Prenatal and Newborn Genetic Testing Market is expected to reach US$ 11,204.74 Mn in 2027 from US$ 4,034.37 in 2018. The market is estimated to grow with a CAGR of 12.2% from 2019-2027. The key factors that are driving the growth of the significant increase in the prevalence of genetic diseases among infants, supportive government for promoting the use of prenatal and newborn testing an...
The global contrast media agents market is expected to reach US$ 6,860.6 Mn in 2027 from US$ 4,855.2 Mn in 2018. The contrast media agents market is estimated to grow with a CAGR of 4.0% from 2019-2027. The market is driven by the factors such as, increasing prevalence of chronic diseases, development in diagnostic imaging modalities coupled with rising numbers of diagnostic test procedures and in...
The global oligonucleotide synthesis market is expected to reach US$ 3,971.72 Mn in 2027 from US$ 1,584.16 Mn in 2018. The market is estimated to grow with a CAGR of 11.1% from 2019-2027. The growth of the oligonucleotide synthesis market is primarily attributed to the increasing applications of synthesized oligonucleotides, increasing investments for synthetic biology, technological advancements ...
The global healthcare CMO market is expected to reach US$ 223,355.6 Mn in 2027 from US$ 80,479.4 in 2018. The healthcare CMO market is estimated to grow with a CAGR of 12.2% from 2019-2027. The market is driven by the factors such as, increasing inclination of pharmaceutical and medical device manufacturers towards outsourcing, increasing patent cliffs and rising geriatric population coupled with...
The global narcolepsy market is expected to reach US$ 4,537.9 Mn in 2027 from US$ 2,026.8 Mn in 2018. The market is estimated to grow with a CAGR of 9.5% from 2019-2027. The growth of the narcolepsy market is primarily attributed to the rising prevalence of sleep related neurological disorders, emerging local pharmaceutical and biopharmaceutical companies, and increasing awareness regarding neurol...
The global bioreactors market is expected to reach US$ 4,811.5 Mn in 2027 from US$ 2,850.2 Mn in 2018. The market is estimated to grow with a CAGR of 6.3% from 2019-2027. The growth of the bioreactors market is primarily attributed to the increasing investments in R&D and other activities. Moreover, the rapid growth of pharmaceutical and biotechnology industry is also expected to drive the growth ...
The global metagenomics market is expected to reach US$ 314.3 Mn in 2027 from US$ 165.8 in 2018. The market is estimated to grow with a CAGR of 7.7% from 2018-2027. Driving factors such as increasing venture capital investments, advantages of metagenomics in biotechnology and industrial applications of metagenomics. Whereas, the trend of the extensive set of molecular-based approaches positive imp...
The global human microbiome market is expected to reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025. The increasing incidence of lifestyle diseases are expected to fuel the market growth during the forecast period. As per World health organization in 2016, 13% of the world population (adults) were obese. According to the "...
The global DNA next generation sequencing market is expected to reach US$ 22,716.9 Mn in 2025 from US$ 4,898.5 Mn in 2017. The market is estimated to grow with a CAGR of 21.7% from 2018-2025. The growth of the DNA next generation sequencing market is attributed to the declining prices of sequencing services as well as various technological advancements in the field of sequencing during the recent ...
In the report the NGS based RNA seq market, the market is expected to reach US$ 7,984.90 Mn in 2027 from US$ 1,414.59 in 2018. The market is estimated to grow with a CAGR of 19.3% from 2018-2027. The NGS based RNA seq market is driven by the driving factor such as reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer However, the market...
In the report the epigenetics market, the market is expected to reach US$ 2,611.57 Mn in 2025 from US$ 991.45 in 2017. The market is estimated to grow with a CAGR of 13.6% from 2017-2025. The epigenetics market is driven by the driving factor such as declining prices of sequencing, and is likely to drive the market in the coming years. The declining costs associated with different strategies and ...